Drawing for NUMARES

USPTO serial 79115519

NUMARES

Reviewed by CopyMark Law Group

Reg. 4464382Status 706Registered
Filing date
Status date
Registration date
Jan 14, 2014
Examiner
DELGIZZI, RONALD ERNEST
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with NUMARES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nathan J. Prepelka, Registration No. 43,016

Nathan J. Prepelka, Registration No. 43,016 The Webb Law Firm420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science; chemical preparations, namely, control solutions, diluents, calibrating substances, reference substances, and concentration markers for analyses in laboratories of human body fluids or their metabolites, of plant extracts, namely, of liquid aqueous or organic plant extracts, and of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, other than for medical or veterinary purposes; chemical reagents other than for medical or veterinary purposes; biological preparations for use in analytic processes, namely, in NMR, namely, nuclear magnetic resonance, analyses, and for use in the identification and quantification of ingredients of chemical or biological compositions, other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary purposes; assortments, namely, kits, comprising, control solutions and calibrating substances for use in industry and science, for analyses in laboratories of human body fluids or their metabolites, of plant extracts, namely, of liquid aqueous or organic plant extracts, and of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, and for the identification and quantification of ingredients of chemical or biological compositions other than for medical or veterinary purposes, NMR, namely, nuclear magnetic resonance, tubes, and a rack for housing said NMR tubesACTIVE—
005Pharmaceutical preparations and veterinary preparations, namely, contrast agents and agents for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; chemical reagents for medical or veterinary purposes, namely, contrast agents and agents for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; chemical reagents for medical or veterinary purposes; chemicals in the nature of diagnostic preparations for medical or veterinary analyses in laboratories; chemico-pharmaceutical preparations, namely, contrast agents and agents for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; chemical preparations for pharmaceutical, medical and veterinary use, namely, for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; biological preparations for medical or veterinary purposes, namely, for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; diagnostic preparations for medical and veterinary use; assortments, namely, kits, comprising, chemicals in the nature of preparations for monitoring metabolic processes, for diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, or for monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes for medical and veterinary purposes, NMR, namely, nuclear magnetic resonance, tubes, and a rack for housing said NMR tubesACTIVE—
009Scientific apparatus and instruments, namely, pipettors, automatic pipetting systems, namely, robotics for moving a sample, robotics for moving NMR, namely, nuclear magnetic resonance, tubes, means for housing containers containing reagents, control substances or calibrating substances, and a pipettor for analyses in laboratories of human body fluids or their metabolites, of plant extracts, namely, of liquid aqueous or organic plant extracts, and of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, centrifuges, namely, laboratory apparatus, glass tubes for scientific purposes and nuclear magnetic instruments; measuring apparatus and instruments, namely, nuclear magnetic instruments; testing apparatus not for medical purposes, namely, nuclear magnetic instruments; food analysis apparatus, namely, nuclear magnetic instruments; diagnosis apparatus, not for medical purposes, namely, nuclear magnetic instruments; spectroscopes; recorded computer software, namely, analytical software used to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, and software for controlling spectroscopes and nuclear magnetic instruments; downloadable computer programs featuring analytical software for use in obtaining results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, and software for controlling spectroscopes and nuclear magnetic instrumentsACTIVE—
042Scientific and technological services and related research and design services, namely, scientific research and development and product research and development in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; industrial analysis and research services in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; computer hardware and software design and development; biological research; computer programming; installation and maintenance of computer software; updating of computer software; rental of computer software; scientific experiments in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; measurement services, namely, performing and evaluating measurements in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; development and research services, namely, analysis services in the nature of scientific analyses in the fields of molecular biology, biochemistry and spectroscopy; development of research methods, namely, of scientific methods in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; development and research services in the fields of molecular biology, biochemistry and spectroscopy; scientific research in the fields of molecular biology, biochemistry and spectroscopy; services of medical and bacteriological research laboratories, namely, medical research and bacteriological research; services of chemical laboratories, namely, medical research and bacteriological research; services of chemical laboratories in the fields of spectroscopy, of analyses of human body fluids or their metabolites, of analyses of plant extracts, namely, of liquid aqueous or organic plant extracts, of analyses of extracts of fermentation processes, namely, of liquid aqueous or organic fermentation process extracts, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetesACTIVE—
045Licensing of computer software in the nature of legal services; licensing of intellectual property rights, namely, industrial property rights and copyrights; licensing of research methodsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 13, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 13, 202571AGREGISTERED-SEC.71 ACCEPTED—
Jan 13, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 11, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 21, 2024ES71TEAS SECTION 71 RECEIVED—
Jan 14, 2023REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Dec 31, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 12, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 24, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Jan 28, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 5, 2020NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Mar 5, 2020C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Mar 5, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 14, 2020ES75TEAS SECTION 71 & 15 RECEIVED—
Jan 14, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 19, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 13, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 28, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 28, 2014FIMPFINAL DISPOSITION PROCESSED—
Apr 14, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 14, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 29, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 29, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 27, 2013GPNXNOTIFICATION PROCESSED BY IB—
Oct 9, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 9, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 9, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 23, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 19, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Sep 19, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 19, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 19, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 22, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 27, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 6, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 31, 2013ALIEASSIGNED TO LIE—
Jan 29, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 13, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 13, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 9, 2012RFNTREFUSAL PROCESSED BY IB—
Aug 22, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 22, 2012RFRRREFUSAL PROCESSED BY MPU—
Aug 22, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 21, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 10, 2012DOCKASSIGNED TO EXAMINER—
Aug 10, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 9, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance